Persius/hicric huggingface dataset:
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Medicare plan may restrict members to a network of providers as long as medically 
necessary covered care is accessible and available through this network. The rules say that the Plan must 
arrange for and cover any medically necessary covered benefit of the plan provider network, but at in-network 
cost sharing, when an in-network provider or benefit is unavailable or inadequate to meet a member's medical 
needs. You can find this rule at 42 CFR Section 422.112(a)(1)(iii). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information on pages 32-37 of the Plan's 2023 
Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that molecular diagnostic laboratory tests must undergo an application and technical assessment 
process through the Molecular Diagnostics (MolDX) contractor. MolDX will review all new test/assay clinical 
information to determine if a test meets Medicares reasonable and necessary requirement. Labs must submit a 
comprehensive dossier on each new test/assay prior to claim submission. MolDX will only cover and 
reimburse tests that demonstrate analytical and clinical validity, and clinical utility at a level that meets the 
Medicare reasonable and necessary requirement. This rule requires that all tests that are approved by this 
process be assigned a unique test identifier from the DEXTM Diagnostics Exchange. Only approved tests will be 
reimbursed consistent with the effective date of the coverage determination. This unique identifier must be 
reported on the claim. You can find this rule in the Local Coverage Determination (LCD): MolDX: Molecular 
Diagnostic Tests (MDT) (L36256) and the related Local Coverage Article: Billing and Coding: MolDX: 
Molecular Diagnostic Tests (MDT) (A57527).  
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare will not pay for dental services. Dental services are items and services involving 
the care, treatment, filling, removal or replacement of teeth or structures directly supporting the teeth. Medicare 
defines "structures directly supporting the teeth" as the periodontium, which includes the gingivae, 
dentogingival junction, periodontal membrane, cementum of the teeth, and alveolar process. You can find this 
rule in the Social Security Act, Section 1862(a)(12) and in the Centers for Medicare and Medicaid Services, 
Internet Only Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 150. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan covers certain dental services as a supplemental (extra) benefit. This benefit includes custom 
fabricated abutment, abutment supported retainer and a pontic when meeting certain criteria. You can find this 
information in Chapter 4 on pages 115 through 130 of the Plans 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
  
  The rules state that Palmetto GBA is concerned that there are no randomized controlled trials (RCTs) that 
specifically evaluated adults = 61 years, few large scale trials on stand-alone LSG and few, if any, long-term 
trials. Palmetto GBA medical directors have also discussed the surgery with subject matter experts in our 
jurisdiction. Given the strengths and limitations of the evidence, Palmetto GBA will cover laparoscopic sleeve 
gastrectomy only when ALL of the following criteria are met: 
 
    Patient has a Body Mass Index (BMI) = 35.0 kg/m2 (Class II or Class III obesity) 
    Patient has at least 1 co-morbidity related to obesity, and, 
    Active participation within the last 12 months prior to bariatric surgery in a weight-management program 
that is supervised by a physician or other health care professionals. The weight-management program must 
include monthly documentation of ALL of the following components: 
        weight 
        current dietary regimen 
        physical activity (e.g., exercise program) 
 
You can find this information in the Local Coverage Determination (LCD) Laparoscopic Sleeve Gastrectomy 
for Severe Obesity L34576. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Prostate Rectal Spacers are coverable ONCE in patients with clinically localized prostate 
cancer with BOTH the following:  
 
1. Inclusion criteria including ALL of the following: 
 
a. Low* or Favorable Intermediate Prostate Cancer Risk Group (1-5) (AUA or NCCN criteria) 
b. Dose escalated (greater than or equal to 76 Gy) conventional fractionation (1.8-2 Gy fractions) 
or moderate hypofractionation (HFX) (2.4-3.4 Gy fractions) IG-IMRT planned  
c. Eastern Cooperative Oncology Group (ECOG) performance status less than or equal to 1 
d. Modern localization techniques insufficient to improve oncologic cure rates and/or reduce side 
effects due to AT LEAST ONE of the following: 
i. Anatomic geometry precluding ideal rectal constraints  
1. Conventional fractionation (V70 less than 10%, V65 less than 20%, V40 less 
than 40%) 
2. Moderate HPX (dose constraints not yet standardized; employ those used in the 
supporting phase III trials) 
ii. Medication usage (e.g., anticoagulants)  
iii. Comorbid conditions (e.g., increased age, Hx MI or CHF) 
 
2. No Exclusion criteria including ALL of the following: 
a. Less than 5-year life-expectancy and asymptomatic 
b. Prior prostate cancer treatment (surgery or RT) 
c. Active bleeding disorder or clinically significant coagulopathy 
d. Active inflammatory or infectious disease in the perineum or injection area (e.g., prostatitis, 
anorectal IBD) 
e. Prostate volume greater than 80 cc 
 
*Life expectancy greater than or 20 y (very low risk); greater than or equal to 10 y (low risk) (7)  
You can find this rule at Centers for Medicare and Medicaid Services, Local Coverage Determination L37485 
entitled Prostate Rectal Spacers. (Full text of rule attached as Regs/Citations in Documentation section) 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on pages 97 to 98 of the Plan's 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules state that for a diagnosis of OSA to be made, the following criteria must be met:  
 
A. Prior to sleep testing, the patient has a face-to-face clinical evaluation by the treating physician to assess the 
patient for OSA which must include, at a minimum, the following: 
 
    Sleep history and symptoms including, but not limited to, snoring, daytime sleepiness, observed apneas, 
choking or gasping during sleep, morning headaches; and, 
    Epworth Sleepiness Scale; and, 
    Physical examination that documents body mass index, neck circumference and a focused cardiopulmonary 
and upper airway system evaluation. 
 
PSG and HST are not indicated to diagnose chronic lung disease. Nocturnal hypoxemia in patients with chronic 
obstructive, restrictive, or reactive lung disease is usually adequately evaluated by oximetry and does not 
require PSG or HST. However, if the patients symptoms suggest a diagnosis of obstructive sleep apnea or 
periodic limb movement disorder, indications for PSG are the same as for those disorders in patients without 
chronic lung disease. 
 
You can find this information in the Local Coverage Determination (LCD) Polysomnography and Sleep 
Testing L33405. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Medicare plan may restrict members to a network of providers as long as medically 
necessary covered care is accessible and available through this network. The rules say that the Plan must 
arrange for and cover any medically necessary covered benefit of the plan provider network, but at in-network 
cost sharing, when an in-network provider or benefit is unavailable or inadequate to meet a member's medical 
needs. You can find this rule at 42 CFR Section 422.112(a)(1)(iii). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information on page 25 of the 2023 Evidence 
of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that when an initial below knee prosthesis (L5500) or a preparatory below knee prosthesis 
(L5510, L5520, L5530, L5540) is provided, prosthetic substitutions and/or additions of procedures and 
components are covered in accordance with the functional level assessment except for codes L5629, L5638, 
L5639, L5646, L5647, L5704, L5785, L5962, and L5980 which will be denied as not reasonable and 
necessary. When a below knee preparatory prefabricated prosthesis (L5535) is provided, prosthetic 
substitutions and/or additions of procedures are covered in accordance with the functional level assessment 
except for codes L5620, L5629, L5645, L5646, L5670, L5676, L5704, and L5962 which will be denied as not 
reasonable and necessary. 
 
More than 2 test (diagnostic) sockets (L5618, L5620, L5622, L5624, L5626, L5628) for an individual 
prosthesis are not reasonable and necessary unless there is documentation in the medical record which justifies 
the need. Exception: A test socket is not reasonable and necessary for an immediate prosthesis (L5400, L5410, 
L5420, L5430, L5450, L5460). 
 
No more than two of the same socket inserts (L5654, L5655, L5656, L5658, L5661, L5665, L5673, L5679, 
L5681, L5683) are allowed per individual prosthesis at the same time. You can find these rules in the Local 
Coverage Determination (LCD) Lower Limb Prostheses L33787. 
 
The rules say that the Infinite Socket (LIM Innovations) is an open-socket design that has distinct below knee 
and above knee products. These sockets are custom fabricated from a model of the patient's residual limb and 
utilize struts that extend from a base to an adjustable brim enclosing an inner shell to form the primary structure 
of the socket. The LIM Innovations socket is functionally equivalent to design features of current HCPCS 
codes. The correct combination of HCPCS codes for the Infinite Socket TT-S (below-knee socket) are L5301 
or L5700 with the addition of L5629, L5637, and L5940. The correct combination of HCPCS codes for the 
Infinite Socket T/F (above-knee socket) are L5321 or L5701 with the addition of L5631, L5649, and L5950. 
 
Codes L5647 and L5652 describe a modification to a prosthetic socket that incorporates a suction valve in the 
design. The items described by these codes are not components of a suspension locking mechanism (L5671). 
You can find these rules in the Local Coverage Article Lower Limb Prostheses - Policy Article A52496. If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that Medicare may cover a drug or biological if it is safe and effective and otherwise reasonable 
and necessary. You can find this rule in the Centers for Medicare and Medicaid Services, Internet Only 
Manual, Publication 100-02, Medicare Benefit Policy Manual, Chapter 15, Section 50.4.1. 
  
Medicare rules also allow the plan to use step therapy. This is the process of beginning drug therapy for a 
medical condition with "preferred" (or more cost-effective) on-formulary drug alternative(s) and progressing to 
other drug therapies only as necessary. A plan must grant an exception to its step therapy rules if it determines 
that the requested drug is medically necessary, consistent with the prescriber's statement. The statement must 
show that the step therapy drugs: have been ineffective in treating the enrollee; or are likely to be ineffective or 
adversely affect the drug's effectiveness or patient compliance; or are likely to cause an adverse reaction or 
other harm to the enrollee.  
 
Medicare Advantage plans should ensure that new step therapy requirements do not disrupt ongoing Part B 
drug therapies for enrollees. Step therapy may only be applied to new prescriptions or administrations of Part B 
drugs for enrollees that are not actively receiving the affected medication. You can find this information at 42 
CFR Sections 422.2 and 422.136. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The contract 
says that the Plan has step therapy requirements for certain Medicare Part B covered drugs/biologicals. 
Enrollees may be required to try a preferred drug before the Plan will approve the requested medication. You 
can find this information on page 86 of the Plan's 2023 Evidence of Coverage (EOC).
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a supplier does not have to deliver supplies used with a CGM every month in order to bill 
code A4238 or A4239 every month. In order to bill code A4238 or A4239, the supplier must have previously 
delivered quantities of supplies that are sufficient to last for one (1) full month, thirty (30) days, following the 
DOS on the claim. Suppliers must monitor usage of supplies. Billing for code A4238 or A4239 may continue 
on a monthly basis as long as sufficient supplies remain to last for one (1) full month, thirty (30) days, as 
previously described. If there are insufficient supplies to be able to last for one (1) full month, thirty (30) days, 
additional supplies must be provided before the supply allowance is billed. 
 
Only one (1) month, thirty (30) days of the supply allowance may be billed to the DME MAC at a time; 
however, suppliers may dispense up to a ninety (90) day supply. You can find this rule at Local Coverage 
Article (LCA) A52464: Glucose Monitor - Policy Article (eff. 10/1/15). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say a health plan must disclose to its enrollees in clear, accurate terms all cost sharing information 
(such as copayments, deductibles and coinsurance). You can find this rule at 42 CFR Section 422.111(a) and 
(b). 
 
The rules say that Original Medicare pays for the routine costs of qualifying clinical trials. Medicare also pays 
for reasonable and necessary items and services used to diagnose and treat complications arising from 
participation in all clinical trials. The rules also say that Medicare plans must cover these services even if they 
are not available through in-network providers. Medicare plans may require reporting when enrollees 
participate in clinical trials but cannot require prior authorization or approval. You can find these rules in the 
Centers for Medicare and Medicaid Services, Internet Only Manual, Publication 100-03, Medicare National 
Coverage Determinations Manual, Chapter 1, Section 310.1. 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that an enrollee who is in a clinical research study may stay enrolled in the Plan and 
continue to get the care that is not related to the study through the Plan. Enrollees must tell the plan before they 
start participating in a clinical research study. 
 
If an enrollee participates in a Medicare-approved study, Original Medicare pays most of the costs for the 
covered services received as part of the study. After Medicare has paid its share of the cost for these services, 
the Plan will also pay for part of the costs. The Plan will pay the difference between the cost-sharing in 
Original Medicare and the cost-sharing as a member of the Plan. This means the enrollee will pay the same 
amount for the services received as part of the study as he or she would if these services were received from the 
Plan. You can find this information on pages 39-40 of the Plan's 2022 Evidence of Coverage (EOC). 
 The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that enrollees must pay 15% of the total cost for each Medicare-covered lab service. You can find 
this information on page 27 of the Plan's 2022 Schedule of Cost Sharing.
Appeal type: unknown
Decision: unknown

 
The rules say that plans must pay for a medical service or item if regular Medicare would pay for it in this case. 
You can find this rule at 42 Code of Federal Regulations (CFR) Section 422.101. 
 
The rules say that a Medicare plan may restrict members to a network of providers as long as medically 
necessary covered care is accessible and available through this network. The rules say that the Plan must 
arrange for and cover any medically necessary covered benefit of the plan provider network, but at in-network 
cost sharing, when an in-network provider or benefit is unavailable or inadequate to meet a member's medical 
needs. You can find this rule at 42 CFR Section 422.112(a)(1)(iii). 
 
If you want to read these Medicare rules, you can go to this website www.medicareappeal.com. 
 
The Plan contract says that the Plan covers items and services in accordance with Medicare rules. The Plan 
contract says that, with limited exceptions, members of the Plan must use network providers to get medical care 
and services. The only exceptions are emergencies, urgently needed care when the network is not available 
(generally, when the enrollee is out of the area), out-of-area dialysis services, and cases in which the Plan 
authorizes the use of out-of-network providers. You can find this information on pages 33 to 38 of the Plan's 
2023 Evidence of Coverage (EOC).